238 results on '"Hoschler, Katja"'
Search Results
2. Serum HCoV-spike specific antibodies do not protect against subsequent SARS-CoV-2 infection in children and adolescents
3. Genomic investigations of unexplained acute hepatitis in children
4. Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK
5. Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2
6. Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Including Omicron in Adolescents: National, Prospective Cohort Study
7. Antibody persistence and neutralising activity in primary school students and staff: Prospective active surveillance, June to December 2020, England
8. Seasonal trivalent inactivated influenza vaccine with topical imiquimod in immunocompromised patients: A randomized controlled trial
9. Seroprevalence of SARS-CoV-2 antibodies in university students: Cross-sectional study, December 2020, England
10. Seroprevalence of SARS-CoV-2 among Blood Donors and Changes after Introduction of Public Health and Social Measures, London, UK
11. Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
12. Humoral response to natural influenza infection in solid organ transplant recipients
13. A Double-Blind, Randomized Trial of High-Dose vs Standard-Dose Influenza Vaccine in Adult Solid-Organ Transplant Recipients
14. Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity
15. Forecasting the 2017/2018 seasonal influenza epidemic in England using multiple dynamic transmission models: a case study
16. End of 2022/23 Season Influenza Vaccine Effectiveness in Primary Care in Great Britain.
17. Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom.
18. Humoral, T-cell and B-cell immune responses to seasonal influenza vaccine in solid organ transplant recipients receiving anti-T cell therapies
19. Author Correction: Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection
20. Optimizing Mood Prior to Influenza Vaccination in Older Adults: A Three-Arm Randomized Controlled Trial.
21. A case of swine influenza A(H1N2)v in England, November 2023.
22. Persistence and avidity maturation of antibodies to A(H1N1)pdm09 in healthcare workers following repeated annual vaccinations
23. Haemagglutination inhibition and virus microneutralisation serology assays: use of harmonised protocols and biological standards in seasonal influenza serology testing and their impact on inter-laboratory variation and assay correlation: A FLUCOP collaborative study
24. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection
25. Coadministration of Seasonal Influenza Vaccine and MVA-NP+M1 Simultaneously Achieves Potent Humoral and Cell-Mediated Responses
26. A Haemophilus sp. dominates the microbiota of sputum from UK adults with non-severe community acquired pneumonia and chronic lung disease
27. High attack rate in a large care home outbreak of SARS-CoV-2 BA.2.86, East of England, August 2023.
28. Administration of AS03 B -adjuvanted A(H1N1)pdm09 Vaccine in Children Aged
29. T-Helper 1 Cells Elicited by H5N1 Vaccination Predict Seroprotection
30. H1N1 Antibody Persistence 1 Year After Immunization With an Adjuvanted or Whole-Virion Pandemic Vaccine and Immunogenicity and Reactogenicity of Subsequent Seasonal Influenza Vaccine: A Multicenter Follow-on Study
31. Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients
32. Fast Rise of Broadly Cross-Reactive Antibodies after Boosting Long-Lived Human Memory B Cells Primed by an MF59 Adjuvanted Prepandemic Vaccine
33. Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccines
34. Evaluation of a virosomal H5N1 vaccine formulated with Matrix M™ adjuvant in a phase I clinical trial
35. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children
36. Immunogenicity and safety of a two-dose schedule of whole-virion and AS03 A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
37. Humoral and Cellular Immunity to Primary H1N1 Infection in Patients with Hematologic Malignancies following Stem Cell Transplantation
38. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study
39. An external quality assessment feasibility study; cross laboratory comparison of haemagglutination inhibition assay and microneutralization assay performance for seasonal influenza serology testing: A FLUCOP study.
40. Incidence of influenza A(H1N1) pdm09 infection, United Kingdom, 2009-2011
41. Cellular immune correlates of protection against symptomatic pandemic influenza
42. Seroprevalence of influenza A(H1N1) pdm09 virus antibody, England, 2010 and 2011
43. Seroepidemiologic study of pandemic (H1N1) 2009 during outbreak in boarding school, England
44. Longevity and Determinants of Protective Humoral Immunity after Pandemic Influenza Infection
45. Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom
46. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine
47. Reproducibility of serologic assays for influenza virus A (H5N1)
48. Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (HSN1) vaccine: phase I randomised trial
49. International flight-related transmission of pandemic influenza A(H1N1)pdm09: an historical cohort study of the first identified cases in the United Kingdom
50. Influenza serological studies to inform public health action: best practices to optimise timing, quality and reporting
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.